Procurement Summary
Country : USA
Summary : Establishing Qualification Processes for Agile Pharmaceutical Manufacturing (Equip-A-Pharma)
Deadline : 20 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 95769995
Document Ref. No. : DARPA-PS-24-12
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative approaches to address challenges in qualifying drug products produced in an agile pharmaceutical manufacturing platform. EQUIP-A-Pharma will aim to develop the technology and process models to demonstrate real-time qualification of multiple drug products produced by reprogramming or reconfiguring the manufacturing platform and inform the creation of a future regulatory framework for agile pharmaceutical manufacturing.
Active Contract Opportunity Notice ID DARPA-PS-24-12 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) Office DEF ADVANCED RESEARCH PROJECTS AGCY
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jan 24, 2024 02:01 pm EST
Original Response Date: Feb 20, 2024 04:00 pm EST
Inactive Policy: Manual
Original Inactive Date: Mar 22, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: AC12 - National Defense R&D Services; Department of Defense - Military; Applied Research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance:
Documents
Tender Notice
DARPA-PS-24-12.pdf
ATTACHMENT_C_SAMPLE_OT_FOR_PROTOTYPE.docx
Attachment_B_OT_Certifications_Template.docx
Attachment_A_Summary_Slide_Template.pptx